Poster Abstracts
Grand Hall CD (Manchester Grand Hyatt)
Utility of Corticosteroids As Adjunct Therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients
Gabriel Bartoo, PharmD, Mayo Clinic;
Moussab Damlaj, MD, Mayo Clinic;
Desire Gijima, MD, University of Iowa;
Julianna Merten, PharmD, Mayo Clinic;
Shahrukh Hashmi, MD, MPH, Mayo Clinic Rochester;
Mark R. Litzow, MD, Mayo Clinic Rochester;
Dennis A. Gastineau, MD, Mayo Clinic;
William Hogan, MBBCh, Mayo Clinic;
Mrinal Patnaik, MBBS, Mayo Clinic
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient
Kathlene DeGregory, PharmD, BCOP, University of Virginia;
Leslie Ward, PharmD, BCPS, BCOP, University of Virginia;
Nicole Watts, PharmD, BCOP, University of Virginia;
Gana Elizabeth Locker, University of Virginia Health System;
Tamila L Kindwall-Keller, DO, MS, University of Virginia School of Medicine;
Lisa Huntsinger, RN, MSN, CCRN, University of Virginia Health System;
Stephanie Mallow-Corbett, PharmD, FCCM, University of Virginia
Retrospective Review of Intravenous Pentamidine for Pneumocystis Pneumonia Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
Reem Diri, PharmD, University of Arizona;
Andrew M. Yeager, MD, Blood and Marrow Transplantation Program;
Ravitharan Krishnadasan, MD, The University of Arizona College of Medicine;
Faiz Anwer, MD, University of Arizona;
Ali McBride, PharmD, MS, The University of Arizona Cancer Center
Voriconazole Therapeutic Drug Monitoring in a Pediatric Hematopoietic Stem Cell Transplant Center
Abby Kim, PharmD, Kosair Children's Hospital;
Joshua Elder, PharmD, BCPS, Kosair Children's Hospital;
Alexandra Cheerva, MD, MS, University of Louisville;
Kenneth Lucas, MD, University of Louisville
Pharmacoeconomic Impact of Thiotepa-Containing Conditioning Regimens in a Pediatric Hematopoetic Stem Cell Transplant Center
Joshua Elder, PharmD, BCPS, Kosair Children's Hospital;
Abby Kim, PharmD, Kosair Children's Hospital;
Alexandra Cheerva, MD, MS, University of Louisville;
Kenneth Lucas, MD, University of Louisville
Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Alex Ganetsky, PharmD, Hospital of the University of Pennsylvania;
Arpita Shah, PharmD, Hospital of the University of Pennsylvania;
Todd A. Miano, PharmD, BCPS, Perelman School of Medicine at the University of Pennsylvania;
Wei-Ting Hwang, PhD, Perelman School of Medicine at the University of Pennsylvania;
Jiwei He, PhD, Perelman School of Medicine at the University of Pennsylvania;
Noelle V. Frey, MD, Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania;
David L. Porter, MD, Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania;
Ran Reshef, MD, Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Low Incidence of Grade II-IV Acute Gvhd Following Tacrolimus and q8h Mycophenolate Mofetil (MMF) Prophylaxis in Pediatric and Young Adult Recipients of Allogeneic Stem Cell Transplantion (AlloSCT)
Olga Militano, PharmD, New York Medical College;
M Fevzi Ozkaynak, MD, New York Medical College;
Daniel Mitchell, BS, New York Medical College;
Karen Wolownik, RN, MSN, CPNP, New York Medical College;
Sandra Fabricatore, RN, MSN, CPNP, New York Medical College;
Carmella van de Ven, MS, New York Medical College;
Mitchell S. Cairo, MD, New York Medical College
Results of the American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Practice Survey – Understanding Today to Meet the Needs of Tomorrow
Ila Maewal Saunders, PharmD, UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences;
Amy W. Bryk, PharmD, The Johns Hopkins Hospital;
JoAl Mayor, PharmD, University of Washington Seattle Cancer Care Alliance;
Rebecca Tombleson, PharmD, Moffitt Cancer Center;
Jeffrey Betcher, BSPharm, Mayo Clinic Arizona;
Beth Eddy, PharmD, University of Kansas Medical Center;
Adam Melaragno, PharmD, University of Rochester Medical Center;
Jill R. Rhodes, PharmD, University of Louisville Hospital / James Graham Brown Cancer Center;
Tippu Khan, PharmD, University of North Carolina;
Susannah Koontz, PharmD, Koontz Oncology Consulting LLC
Intravenous Pentamidine for Pneumocystis Carinii/Jiroveci Pneumonia (PCP) Prophylaxis
Abigail Clark, PharmD, Memorial Sloan-Kettering Cancer Center;
Ashley Teusink, PharmD, MBA, BCPS, Cincinnati Children's Hospital Medical Center;
Lara Danziger-Isakov, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center;
Trina Hemmelgarn, Cincinnati Children's Hospital Medical Center
![[Visit Client Website]](images/banner.gif)